$8.01 (0.250%)

Volume: 2.244M

Closed: May 26, 2023

Hollow Logo Score: -4.373
BioCryst Pharmaceuticals Stock
$8.01 (0.250%)

Volume: 2.244M

Closed: May 26, 2023

Score Hollow Logo -4.373
NASDAQ:BCRX

BioCryst Pharmaceuticals Stock Price (Quote)

$8.01 ( 0.250% ) Friday, 26th May 2023

Range Low Price High Price Comment
30 days $7.28 $9.07 Friday, 26th May 2023 BCRX stock ended at $8.01. This is 0.25% more than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 3.71% from a day low at $7.82 to a day high of $8.11.
90 days $7.20 $9.20
52 weeks $7.20 $15.43

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
2023-05-26 $8.01 $8.11 $7.82 $8.01 2 244 012
2023-05-25 $8.21 $8.21 $7.91 $7.99 2 323 997
2023-05-24 $8.78 $8.78 $8.15 $8.22 3 000 739
2023-05-23 $8.59 $8.92 $8.57 $8.77 3 198 009
2023-05-22 $8.43 $8.62 $8.43 $8.57 2 576 675
2023-05-19 $8.48 $8.51 $8.33 $8.44 2 045 682
2023-05-18 $8.49 $8.49 $8.27 $8.37 2 031 948
2023-05-17 $8.48 $8.66 $8.41 $8.47 2 801 290
2023-05-16 $8.55 $8.55 $8.37 $8.46 2 254 687
2023-05-15 $8.36 $8.91 $8.31 $8.77 2 345 284
2023-05-12 $8.37 $8.45 $8.25 $8.30 1 832 877
2023-05-11 $8.56 $8.59 $8.35 $8.36 2 020 307
2023-05-10 $8.66 $8.82 $8.57 $8.63 1 539 373
2023-05-09 $8.41 $8.66 $8.39 $8.58 2 223 858
2023-05-08 $8.54 $8.62 $8.42 $8.49 2 588 407
2023-05-05 $8.52 $8.62 $8.21 $8.56 3 163 512
2023-05-04 $8.35 $8.52 $8.00 $8.47 3 126 234
2023-05-03 $8.13 $9.07 $8.00 $8.29 7 327 166
2023-05-02 $7.50 $7.55 $7.28 $7.37 3 328 437
2023-05-01 $7.59 $7.63 $7.45 $7.51 2 846 473
2023-04-28 $7.49 $7.67 $7.48 $7.61 1 845 637
2023-04-27 $7.72 $7.75 $7.45 $7.53 1 912 096
2023-04-26 $7.48 $7.69 $7.42 $7.62 1 942 228
2023-04-25 $7.58 $7.58 $7.41 $7.49 2 062 315
2023-04-24 $7.51 $7.61 $7.36 $7.61 2 772 736
2023-04-21 $7.40 $7.55 $7.27 $7.52 2 594 852
2023-04-20 $7.39 $7.55 $7.27 $7.38 3 213 738
2023-04-19 $7.46 $7.54 $7.40 $7.49 3 267 024
2023-04-18 $7.96 $7.97 $7.20 $7.50 6 892 984
2023-04-17 $8.15 $8.26 $8.05 $8.07 5 541 778
2023-04-14 $8.38 $8.38 $8.00 $8.07 3 674 883
2023-04-13 $8.41 $8.61 $8.39 $8.41 2 995 126
2023-04-12 $8.59 $8.62 $8.34 $8.34 1 371 089
2023-04-11 $8.57 $8.58 $8.45 $8.50 1 635 146
2023-04-10 $8.61 $8.80 $8.37 $8.52 1 862 865
2023-04-06 $8.56 $8.78 $8.44 $8.68 2 672 341
2023-04-05 $8.32 $8.58 $8.29 $8.53 2 371 358
2023-04-04 $8.41 $8.43 $8.22 $8.30 3 001 148
2023-04-03 $8.31 $8.49 $8.23 $8.37 1 935 346
2023-03-31 $8.48 $8.56 $8.30 $8.34 2 753 202
2023-03-30 $8.64 $8.71 $8.31 $8.39 2 042 406
2023-03-29 $8.62 $8.69 $8.37 $8.56 2 567 972
2023-03-28 $8.43 $8.65 $8.35 $8.59 2 047 206
2023-03-27 $8.48 $8.57 $8.37 $8.46 1 449 361
2023-03-24 $8.11 $8.57 $8.08 $8.50 2 697 700
2023-03-23 $7.99 $8.32 $7.95 $8.12 2 018 253
2023-03-22 $8.16 $8.24 $7.92 $7.94 1 951 420
2023-03-21 $8.05 $8.24 $7.95 $8.17 1 985 852
2023-03-20 $8.13 $8.13 $7.95 $8.01 2 025 911
2023-03-17 $8.08 $8.18 $8.01 $8.10 5 228 495
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT